Primary Peritoneal Carcinoma Terminated Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00322881Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian CancerTreatment
NCT00004221Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian CancerTreatment
NCT00582205Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal CarcinomaTreatment